Listed

CF Bankshares Inc.: Form 10-Q for the period ended Sep 30, 2025

Filed with the SEC on Nov 7, 2025 and accepted by EDGAR at Nov 7, 2025, 09:16 ET.

Share

Management's discussion and analysis

As filed, 1,529 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

(a) None.

(b) Not applicable.

(c) The following table provides information concerning purchases of the Holding Company’s shares of common stock made by or on behalf of the Company or any “affiliated purchaser” as defined in Rule 10b-18(a)(3) under the Exchange Act, during the three months ended September 30, 2025.

Period Total number of common shares purchased Average price paid per common share Total number of common shares purchased as part of publicly announced plans or programs (2) Maximum number of common shares that may yet be purchased under the plans or programs
July 1, 2025 through July 31, 2025 3,425 (1) 23.49 3,240 289,622
August 1, 2025 through August 31, 2025 — — — 289,622
September 1, 2025 through September 30, 2025 — — — 289,622
Total 3,425 $23.49 3,240

(1) Includes 185 shares of common stock surrendered to the Company for the payment of taxes upon the vesting of restricted stock and 3,240 shares of common stock repurchased under the stock repurchase program.

(2) On February 4, 2025, the Company's Board of Directors authorized a new stock repurchase program pursuant to which the Company is authorized to repurchase up to an aggregate of 325,000 shares, or approximately 5% of the Company's outstanding common stock, on or before January 31, 2026. As of September 30, 2025, 289,622 shares remained available to be purchased by the Company under this stock repurchase program.

Risk factors

As filed, 459 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There are certain risks and uncertainties in our business that could cause our actual results to differ materially from those anticipated. A detailed discussion of our risk factors is included in “Item 1A. Risk Factors” of Part I of the Company’s Annual Report on Form 10-K for the year ended December 31, 2024. There were no material changes to those risk factors as presented in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2025-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Income tax3 months2025-07-01 to 2025-09-30$373.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2025-01-01 to 2025-09-30$2.9mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2025-07-01 to 2025-09-30$2.3mus-gaap:NetIncomeLoss
Net income9 months2025-01-01 to 2025-09-30$11.8mus-gaap:NetIncomeLoss
Diluted EPS3 months2025-07-01 to 2025-09-30$0.36us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2025-01-01 to 2025-09-30$1.81us-gaap:EarningsPerShareDiluted
Basic EPS3 months2025-07-01 to 2025-09-30$0.36us-gaap:EarningsPerShareBasic
Basic EPS9 months2025-01-01 to 2025-09-30$1.82us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2025-07-01 to 2025-09-306,346,243 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2025-01-01 to 2025-09-306,325,600 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2025-01-01 to 2025-09-30$15.6mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2025-01-01 to 2025-09-30$432.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2025-01-01 to 2025-09-30$1.4mus-gaap:PaymentsOfDividendsCommonStock
Cash and equivalentsAt period end2025-09-30$272.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Total assetsAt period end2025-09-30$2.11bnus-gaap:Assets
Total liabilitiesAt period end2025-09-30$1.93bnus-gaap:Liabilities
Shareholders' equityAt period end2025-09-30$179.3mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001193125-25-271208. Last ingested by Listed: Nov 13, 2026, 01:50 ET. Listed shows no prices and gives no investment advice.